Type 2 diabetes is a risk factor for dementia and Alzheimer’s. Novo Nordisk, which makes Ozempic and Wegovy, is running two ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

Health and wellness companies are responding in kind, with recent market developments coming from: PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF), Novo Nordisk A/S (NYSE: NVO), Eli Lilly and Company ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) drug, and is the active agent in Ozempic and its weight-loss cousin, Wegovy.